Digital Morphology Analyzer-Based White Blood Cell Differentials: Practical Considerations for External Quality Assessment
Annals of Laboratory Medicine · 19.08.2026
DOI: 10.3343/alm.2026.0097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Laboratory Medicine, online erschienen am 19.08.2026. Verfasst von Hongkyung Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea. Gefördert von: Laboratory Medicine Foundation.
Abstract (Originalsprache)
Background
Digital morphology (DM) analyzers are increasingly used for white blood cell (WBC) differential counting in routine hematology laboratories, necessitating tailored external quality assessment (EQA) schemes. We evaluated EQA-relevant practical considerations for DM analyzer-based WBC differentials.
Methods
Fifteen clinical laboratories participated in a multicenter EQA simulation using five centrally prepared, unstained peripheral blood smear samples. Institution-level post-classification results were analyzed as the primary outcomes. Exploratory analyses were performed using pre-classification and manual microscopic differentials. Examiner-level variability within institutions was evaluated, along with the distributions of WBC-classified and unclassified images following examiner verification.
Results
Most participating laboratories used DM analyzers primarily for screening WBC differentials, with predefined criteria for manual microscopic reviews, particularly when abnormal cell populations were noted. Inter-institutional and examiner-level variability were most pronounced for morphologically similar cell classes. Post-classification results were generally comparable with those of manual differentials across most cell classes. The proportion of unclassified images (including artifacts) increased, suggesting that operational and sample-related factors influenced the interpretation of the EQA results.
Conclusions
We identified key practical considerations for the EQA of DM analyzer-based WBC differential counting. An appropriate EQA design should incorporate clinically relevant abnormal cell populations and challenging sample types; data interpretation should extend beyond standard deviation index-based metrics to address abnormal cell detection. The overall concordance between post-classification results and manual differentials supports the importance of periodic verification, and slide quality should be considered when implementing DM analyzer-based EQA programs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
- Department of Laboratory Medicine, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea.
- Department of Laboratory Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.
ORCID-Profile: Hongkyung Kim, Oh Joo Kweon, Sumi Yoon, Yong Kwan Lim, Bohyun Kim
Förderung
- Laboratory Medicine Foundation
Zitieren
APA
Kim, H., Kweon, O. J., Yoon, S., Lim, Y. K., & Kim, B. (2026). Digital Morphology Analyzer-Based White Blood Cell Differentials: Practical Considerations for External Quality Assessment. Annals of Laboratory Medicine. https://doi.org/10.3343/alm.2026.0097
Vancouver
Kim H, Kweon OJ, Yoon S, Lim YK, Kim B. Digital Morphology Analyzer-Based White Blood Cell Differentials: Practical Considerations for External Quality Assessment. Annals of Laboratory Medicine. 2026. doi:10.3343/alm.2026.0097
BibTeX
@article{Kim2026,
author = {Kim, Hongkyung and Kweon, Oh Joo and Yoon, Sumi and Lim, Yong Kwan and Kim, Bohyun},
title = {Digital Morphology Analyzer-Based White Blood Cell Differentials: Practical Considerations for External Quality Assessment},
journal = {Annals of Laboratory Medicine},
year = {2026},
doi = {10.3343/alm.2026.0097}
}
EUVIMED